The U.K. Prospective Diabetes Study: A review

Diabetes Care

Volumn 21, Issue 12 SUPPL., 1998, Pages

  Turner, Robert C ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORPROPAMIDE; GLIBENCLAMIDE; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; INSULIN ZINC SUSPENSION; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METFORMIN; SULFONYLUREA DERIVATIVE;

ADULT; AGED; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC ANGIOPATHY; DIABETIC DIET; DIABETIC MICROANGIOPATHY; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; HYPOGLYCEMIA; INSULIN TREATMENT; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET BETA CELL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SMOKING; UNITED KINGDOM; WEIGHT GAIN;

EID: 0031729818     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.21.3.c35     Document Type: Conference Paper

References (21)

1. Reichard P, Nilsson B-Y, Rosenqvist U: The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus. N Engl J Med 329:304-309, 1993
2. Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986, 1993
3. Ohkubo Y, Kishikawa H, Araki E, Miyata T, Isami S, Motoyoshi S, Kojima Y, Furuyoshi N, Shiahir M: Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin dependent diabetes mellitus: a randomized, prospective 6 year study Diabetes Res Clin Pract 28:103-117, 1995
4. Meinart CL, Knatterud GL, Prout TE, Klimt CR: A study of the effects of hypoglycemic agents on vascular complications with adult-onset diabetes. II. Mortality results. Diabetes 19 (Suppl, 1):789-830, 1970
5. University Group Diabetes Program: A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. V. Evaluation of phenformin therapy. Diabetes 24 (Suppl. 1):65-184, 1975
6. Chutkow WA, Simon MC, Le Beau MM, Burant CF: Cloning, tissue expression, and chromosomal localization of SUR2, the putative drug-binding subunit of cardiac, skeletal muscle, and vascular KATP channels. Diabetes 45:1439-1445, 1996
7. Smits P, Thien T: Cardiovascular effects of sulphonylurea derivatives: implications for the treatment of NIDDM? Diabetologia 38:116-121, 1995
8. Stout RW: Insulin and atherosclerosis. In Diabetes and Atherosclerosis. Stout RW, Ed. Dordrecht, the Netherlands, Kluwer, 1992, p. 165-201
9. U.K. Prospective Diabetes Study Group: U.K. Prospective Diabetes Study (UKPDS). VIII. Study design, progress and performance. Diabetologia 34:877-890, 1991
10. Jarrett RJ, Keen H: Hyperglycaemia and diabetes mellitus. Lancet ii: 1009-1012, 1976
11. Pettilt DJ, Knowler WC, Lisse JR, Bennett PH: Development of retinopathy and proteinuria in relation to plasma-glucose concentrations in Pima Indians. Lancet ii:1050-1052, 1980
12. Fuller JH, Shipley MJ, Rose G, Jarrett RJ, Keen H: Coronary-heart-disease risk and impaired glucose tolerance: the Whitehall Study, Lancet i: 1373-1376, 1980
13. Folsom AR, Szklo M, Stevens J, Liao F, Smith R, Eckfeldt JH: A prospective study of coronary heart disease in relation to fasting insulin, glucose, and diabetes: the Atherosclerosis Risk in Communities (ARIC) Study. Diabetes Care 20:935-942, 1997
14. U.K. Prospective Diabetes Study Group: U.K. Prospective Diabetes Study 16. Overview of 6 years' therapy of type II diabetes: a progressive disease. Diabetes 44: 1249-1258, 1995
15. Turner R, Cull C, Holman R: United Kingdom Prospective Diabetes Study 17: a 9-year update of a randomized, controlled trial on the effect of improved metabolic control on complications in non-insulin-dependent diabetes mellitus. Ann Intern Med 124 (pt 2):136-145, 1996
16. Turner RC, Millns H, Neil HAW, Stratton IM, Manley SEM, Matthews DR, Holman RR: UKPDS 23: risk factors for coronary artery disease in type 2 diabetes. BMJ. 316:823-828, 1998
17. Pyorala K, Savolainen E, Lehtovirta E, Punsar S, Siltanen P: Glucose tolerance and coronary heart disease: Helsinki policemen study. J Chronic Dis 32:729-745, 1979
18. Despres JP, La marche B, Mauriege P, Cantin B, Dagenais GR, Moorjani S, Lupien PJ: Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med 334:952-957, 1996
19. Klein R: Hyperglycemia and microvascular and macrovascular disease in diabetes. Diabetes Care 18:258-268, 1995
20. Rudenski AS, Hadden DR, Atkinson AB, Kennedy L, Matthews DR, Merrett JD, Pockaj B, Turner RC: Natural history of pancreatic islet β-cell function in type 2 diabetes mellitus studied over six years by homeostasis model assessment. Diabet Med 5:36-41, 1988
21. Stratton I, Manley S, Holman R, Turner R: Hypertension in Diabetes Study IV Therapeutic requirements to maintain tight blood pressure control. Diabetologia 39:1554-1561, 1996 (Published erratum appears in Diabetologa 40:366, 1997)